Select Location:

Dr. Shyam Rathi

Consultant

M.B.B.S, MD (Internal Medicine), DM (Clinical Haematology)

Bone Marrow Transplantation and Haematological Malignancies at University of British Columbia, Vancouver, British Columbia, Canada (2010-11).

Services Offered
Internal Medicine and Clinical Hematology
Education & Training

  • M.B.B.S – Amravati University, Maharashtra, Ranked third in the final year of academics – 2000.
  • MD (Internal Medicine) – K. J. Somaiya Medical College, University of Mumbai, Maharashtra – 2006.
  • DM (Clinical Haematology) – From All India Institute of Medical Sciences, Delhi, India - 2010.

Experience

9 years

Languages Spoken

English and Hindi

Doctor's Availability

Monday
to
Make an Appointment
Tuesday
to
Make an Appointment
Wednesday
to
Make an Appointment
Thursday
to
Make an Appointment
Friday
to
Make an Appointment
Saturday
to
Make an Appointment

Professional Highlights

Research projects:

1. Phase II / III trial: Evaluation of Lenalidomide + Cyclophosphamide + Prednisolon combination therapy in multiple myeloma. Project completed as a part of thesis in DM Haematology and submitted to the institute.

2. Study of JAK2 mutation in patients with splanchnic venous thrombosis. Project completed as a part of thesis in DM Haematology and submitted to the institute.

Publications and Presentations:

1) Rathi Shyam, Mahapatra M, Mishra P, Gupta N, Kapoor R, Pati H. To study efficacy and toxicity of lenalidomide, cyclophosphamide and prednisone combination therapy in multiple myeloma. Oral presentation. Indian society of hematology and transfusion medicine (annual meeting). Delhi 2009. Abstract no. 032. Online IJHBT issue DEC 2009.

2) Rathi Shyam, Sazawal S, Chikara T, Seth T, Saraya A, Saxena R. Prevalence of JAK2 mutation in patients with splanchnic vein thrombosis, AIIMS experience. Indian society of hematology and transfusion medicine (annual meeting). Delhi 2009. Abstract no. 078.

3) Rathi Shyam, Sazawal S, Bharti Sharma. Role of JAK2 mutation in patients with splanchnic vein thrombosis: AIIMS experience. Abstract no. 1017 at the 14th Annual Meeting of European Haematology Association, Berlin, June 2009 (available online at hematologica journal).

4) Rathi Shyam, Sazawal S, Bharti Sharma. Evaluation of JAK2 mutation in patients with splanchnic vein thrombosis. Oral presentation. Abstract no. 78 at the Internation Society of Haematology. Bangkok, 2008. (published in ISH abstract book.

5) Rathi Shyam. PTLD Management - An overview. Post- transplant lymphoproliferative disorder book 2010.

6) Rathi Shyam, M Mahapatra. Approach to Polycythemia Vera. Hematology Today book 2010.

7) Rathi Shyam, Agrawal Narendra. Acquired sideroblastic anemia. Iron disorder book 2010.

8) Agarwal MB, Rathi Shyam A. Haematological disorders in pregnancy. Medical Disorders in Pregnancy. ECAB clinical update. Obstetrics and Gynaecology. Ed- Thanawala U, Diwakar H. Elsevier. 2009. Pp75-96.

9) Rathi Shyam A. RQ-PCR (including micro RNAs) based prognostic scoring system for CLL. Haem Onc (India): Newsletter. CLL, April 2009.

10) Agarwal DK, Bhargava R, Dolai T K, Singhal D, Mahapatra M, Rathi Shyam A, Bohra B, Rathod N. An unusual presentation of eosionophilic variant of chronic myeloid leukemia (eoCML). Ann Haematol. 2009;88:89-90

11) Dolai T K. Kumar R. Bhargava R, Mahapatra M. Mishra P, Seth T, Kar R, Rathi Shyam A, Pati H P, Saxena R, Tyagi S, Multiorgan failure due to Mycobacterium tuberculosis and Aspergillus flavus infection after allogenic bone marrow transplantation. Ind J Haemat Blood Trans. 2008;24:78-80.

12) Bhargava R, Dolai T K, Singhal D, Mahapatra M, Mishra P, Rathod N, Rathi Shyam A. Pure red cell aplasia associated with thymoma: Is thymectomy the cure? Leukemia Research;2008;May20.(ahed of print). Available online from 21 May 2008.

13) Agarwal mb, Rathi Shyam A, Rathod N, Subramanian R. Caspogungin : A major breakthrough in treatment of systemic fungal infections. J. Assoc. Phys India. 2006;54:943-8.

14) Agarwal mb, Rathi Shyam A, Rathi Sonali S. Molecular techniques in haematological malignancy : From bench of bedside. Haematology Today – 2008. Proceedings of the XIV National CME in Haematology, Mumbai, India. 2008:541-550.

15) Pati H P, Rathi Shyam A, Kar Rakhee. Bone marrow biopsy in myelodysplastic syndrome. ISHTM. Annual conference booklet, 2008.

16) Agarwal MB, Rathi Shyam A, Jain Punit, Rathi Sonali S, Agarwal Usha M. Management of ITP:Current strategies. Haematology Today 2009.

17) Agarwal MB, Rathi Shyam A, Jain Punit, Rathi Sonali S, Agarwal Usha M, Cytogenetics of Myelodysplastic Syndrome. Chapter 2. Haematology Today 2009.

18) Shyam A Rathi, Punit Jain, Sonali S. Rathi, Usha M. Agarwal M.B., Agarwal. Haematological disorders in pregnancy. Chapter 63. Haematology Today 2009.

19) M.B. Agarwal, Tahir Shamsi, Shyam A. Rathi, Punit Jain, Sonali S. Rathi, Usha M. Agarwal. How to interpret Histogram ? Chapter 64. Haematology Today 2009.

20) Rathi Shyam, Rathi Shonali, Raut Lalit, Ekbote Venkatesh. Deferasirox : The oral, once daily, effective and safe iron chelator for thalassaemics and others. Chapter 50. Haematology Today – 2008.

21) Agarwal MB, Rathi Shyam, Raut Lalit, Rathi Shonali. In critically ill patients, what should be the ideal transfusion trigger ? Chapter 60. Haematology Today – 2008.

22) Agarwal MB, Rathi Shyam A, Rathod Niranjan, Subramanian R. Casprofungin : A major breakthrough in treatment of systemic fungal infections. Haematology Today – 2007. Education Book published at the occasion of XIII National CME in Haematology, Mumbai, India. 2007:535-544.

23) Agarwal MB, Rathi Shyam A. Management of immune thrombocytopenic purpure in adults. Haematology Today - 2007. Education Book published at the occasion of XIII National CME in Haematology, Mumbai, India. 2007:309-324.

24) Agarwal MB, Rathi Shyam. Umbilical cord blood transplantation. Newer trends. Haematology Today-2006, Chapter no. 32.pp301-8.

25) Rathi Shyam A. Homoherringtonin. CML News Letter. 2007.

26) Rathi Shyam A. Pictorial Quiz. CML News Letter. 2007, Aug. Vol. 13.

27) Rathi Shyam A. Check your knowledge regarding Imatinib mesylate. CML News Letter. 2007, Aug. Vol. 2.27.

28) Rathi Shyam A. Neutrophil alkaline phospatase (NAP) score. CML News Letter. 2008,Jan. Vol. 1.4.

29) Rathi Shyam A. Sudden blastic transformation during imatinib therapy. CML News Letter. 2008, April. Vol. 2.18.

30) Rathi Shyam A. Imatinib therapy and bone formation (synopsis). CML News Letter. 2008,. Vol. 2.15.

31) Rathi Shyam A. 5q syndrome. MDS Newsletter. 2008.

32) Rathi Shyam A. Imatinib : Drug influx and efflux in leukaemic cells. CML Newsletter – December 2008. Vol.2.

33) Gupta N, Kapoor R, Rathi S, Seth T, Mishra P, Mahapatra M, Pati H. lenalidomide in low risk myelodysplastic syndrome : single centre experience. Indian society of hematology and transfusion medicine. (annual meeting). Delhi, 2009. Abstract no. 029. Online IJHBT issue DEC 2009.

34) Gupta N, Sharma P, Rathi S, Pati H, Mahapatra M. Bone marrow aplasia in two MDS patients treated with Lenalidomide. Indian society of hematology and transfusion medicine (annual meeting). Delhi, 2009. Abstract no. P42. Online IJHBT issue DEC 2009.

35) Rathod N, Dhingra B, Rathi S, Mishra P, Mahapatra M, Seth T. Castleman disease: A report of two cases. Indian society of hematology and transfusion medicine (annual meeting). Delhi, 2009. Abstract no. P40, online IJHBT issue DEC 2009.

36) Gupta N, Mahapatra M, Rathi S, Kapoor R, Singh A, Seth T, Mishra P. acute renal failure following antithymocyte globulin therapy for aplastic anaemia-report of two cases and review of literature. Ann Hematol.2010 Jun 11. [Epub ahed of print].

37) Gupta N, Gupta SK, Rathi S, Sharma SK, Mahapatra M, Seth T, Mishra P, Saxena R. Acute lymphoblastic leukemia presenting as non-oliguric renal failure and hypertension. Leuk Res. 2010 Jul;34(7):e150-1. Epub 2010 Jan 20.

Request An Appointment With Dr. Shyam Rathi

...

...

...

...